TrialInternational journal of clinical oncology2016

A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer.

Hideyuki Akaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.